Tarek El Hoss Joins MedX Health Senior Managment

MedX Health Corp. has appointed Tarek El Hoss as vice president, Market Development and Sales. El Hoss will oversee strategic global growth initiatives and will be responsible for the deployment of market development strategies to impact immediate revenue generation and growth.

“Over the past year, we’ve announced commercial partnerships to make our DermSecure skin screening technology available to serve patients throughout Europe, the Middle East and Canada,” MedX President and CEO Naman Demaghlatrous said. “Tarek’s extensive knowledge of the global medical technology marketplace and expertise in establishing country specific go-to-market strategies will be crucial to the next phase of our company’s growth and we’re delighted to have him join our team.”
 
El Hoss has more than 20 years of demonstrated success in the medical technology industry, including a lengthy tenure as business director, Middle East, Africa, Central Asia, and Turkey for Medtronic plc, where he was responsible for implementing and driving sales strategies while establishing distribution channels and launching new products throughout his geography of responsibility.
 
“I am excited to join a team that is driven by a global mindset,” stated El Hoss. “Leveraging and strengthening our existing partnerships while seeking out and building others will improve access to our best-in-class, innovative teledermatology platform for patients around the world. I am looking forward to expanding MedX’s international footprint and offering a solution to improving patient outcomes at the same time.”
 
MedX’s telemedicine platform allows healthcare practitioners to quickly and accurately assess suspicious moles, lesions and other skin conditions via its image-capture technology, SIAscopy, and its secure, cloud-based patient management system, DermSecure, which transmits and stores patient data throughout the assessment process. MedX’s SIAscopy is the only technology that captures five images, including four spectrophotometric images 2mm below the skin’s surface. Teledermatology is a subspecialty of dermatology that offers safe and effective virtual patient assessment and diagnosis at a distance, eliminating the need for in-person appointments.
 
Headquartered in Ontario, Canada, MedX is a medical device and software company focused on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also imbedded in its products SIAMETRICS, SIMSYS, and MoleMate, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS, SIMSYS, and MoleMate include handheld devices that use patented technology utilizing light and its remittance to view suspicious moles and lesions up to 2mm beneath in a pain-free, non-invasive manner. Its patented software then creates real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration, and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil, and Turkey.